Advanced search
1 file | 5.99 MB
Author
Organization
Abstract
Cell death of hepatocytes is a prominent characteristic in the pathogenesis of liver disease, while hepatolysis is a starting point of inflammation in hepatitis and loss of hepatic function. However, the precise molecular mechanisms of hepatocyte cell death, the role of the cytokines of hepatic microenvironment and the involvement of intracellular kinases, remain unclear. Tumor necrosis factor alpha (TNF-alpha) is a key cytokine involved in cell death or survival pathways and the role of RIPK1 has been associated to the TNF-alpha-dependent signaling pathway. We took advantage of two different deficient mouse lines, the RIPK1 kinase dead knock-in mice (Ripk1K45A) and the conditional knockout mice lacking RIPK1 only in liver parenchymal cells (Ripk1LPC-KO), to characterize the role of RIPK1 and TNF-alpha in hepatitis induced by concanavalin A (ConA). Our results show that RIPK1 is dispensable for liver homeostasis under steady-state conditions but in contrast, RIPK1 kinase activity contributes to caspase-independent cell death induction following ConA injection and RIPK1 also serves as a scaffold, protecting hepatocytes from massive apoptotic cell death in this model. In the Ripk1LPC-KO mice challenged with ConA, TNF-alpha triggers apoptosis, responsible for the observed severe hepatitis. Mechanism potentially involves both TNF-independent canonical NF-kappa B activation, as well as TNF-dependent, but canonical NF-kappa B-independent mechanisms. In conclusion, our results suggest that RIPK1 kinase activity is a pertinent therapeutic target to protect liver against excessive cell death in liver diseases.
Keywords
TUMOR-NECROSIS-FACTOR, NF-KAPPA-B, MURINE ACETAMINOPHEN TOXICITY, A-INDUCED HEPATITIS, HEPATOCELLULAR-CARCINOMA, IL-33 EXPRESSION, IN-VIVO, MOUSE HEPATOCYTES, INDUCED APOPTOSIS, KINASE-ACTIVITY

Downloads

  • 2753 16Filliol.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 5.99 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Filliol, Aveline, Claire Piquet-Pellorce, Jacques Le Seyec, Muhammad Farooq, Valentine Genet, Catherine Lucas-Clerc, John Bertin, et al. 2016. “RIPK1 Protects from TNF-α-mediated Liver Damage During Hepatitis.” Cell Death & Disease 7.
APA
Filliol, A., Piquet-Pellorce, C., Le Seyec, J., Farooq, M., Genet, V., Lucas-Clerc, C., Bertin, J., et al. (2016). RIPK1 protects from TNF-α-mediated liver damage during hepatitis. CELL DEATH & DISEASE, 7.
Vancouver
1.
Filliol A, Piquet-Pellorce C, Le Seyec J, Farooq M, Genet V, Lucas-Clerc C, et al. RIPK1 protects from TNF-α-mediated liver damage during hepatitis. CELL DEATH & DISEASE. 2016;7.
MLA
Filliol, Aveline et al. “RIPK1 Protects from TNF-α-mediated Liver Damage During Hepatitis.” CELL DEATH & DISEASE 7 (2016): n. pag. Print.
@article{8510060,
  abstract     = {Cell death of hepatocytes is a prominent characteristic in the pathogenesis of liver disease, while hepatolysis is a starting point of inflammation in hepatitis and loss of hepatic function. However, the precise molecular mechanisms of hepatocyte cell death, the role of the cytokines of hepatic microenvironment and the involvement of intracellular kinases, remain unclear. Tumor necrosis factor alpha (TNF-alpha) is a key cytokine involved in cell death or survival pathways and the role of RIPK1 has been associated to the TNF-alpha-dependent signaling pathway. We took advantage of two different deficient mouse lines, the RIPK1 kinase dead knock-in mice (Ripk1K45A) and the conditional knockout mice lacking RIPK1 only in liver parenchymal cells (Ripk1LPC-KO), to characterize the role of RIPK1 and TNF-alpha in hepatitis induced by concanavalin A (ConA). Our results show that RIPK1 is dispensable for liver homeostasis under steady-state conditions but in contrast, RIPK1 kinase activity contributes to caspase-independent cell death induction following ConA injection and RIPK1 also serves as a scaffold, protecting hepatocytes from massive apoptotic cell death in this model. In the Ripk1LPC-KO mice challenged with ConA, TNF-alpha triggers apoptosis, responsible for the observed severe hepatitis. Mechanism potentially involves both TNF-independent canonical NF-kappa B activation, as well as TNF-dependent, but canonical NF-kappa B-independent mechanisms. In conclusion, our results suggest that RIPK1 kinase activity is a pertinent therapeutic target to protect liver against excessive cell death in liver diseases.},
  articleno    = {e2462},
  author       = {Filliol, Aveline and Piquet-Pellorce, Claire and Le Seyec, Jacques and Farooq, Muhammad and Genet, Valentine and Lucas-Clerc, Catherine and Bertin, John and Gough, Peter J and Dimanche-Boitrel, Marie-Thérèse and Vandenabeele, Peter and Bertrand, Mathieu and Samson, Michel},
  issn         = {2041-4889},
  journal      = {CELL DEATH & DISEASE},
  keywords     = {TUMOR-NECROSIS-FACTOR,NF-KAPPA-B,MURINE ACETAMINOPHEN TOXICITY,A-INDUCED HEPATITIS,HEPATOCELLULAR-CARCINOMA,IL-33 EXPRESSION,IN-VIVO,MOUSE HEPATOCYTES,INDUCED APOPTOSIS,KINASE-ACTIVITY},
  language     = {eng},
  pages        = {13},
  title        = {RIPK1 protects from TNF-α-mediated liver damage during hepatitis},
  url          = {http://dx.doi.org/10.1038/cddis.2016.362},
  volume       = {7},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: